Biologic and Targeted Synthetic Disease-Modifying Antirheumatic Drugs Do Not Arrest Bone Loss in Patients With Rheumatoid Arthritis: A Long-Term Multicenter Observational Study - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Long-Term Multicenter Observational Study Reveals No Impact of Biologic and Targeted Synthetic DMARDs on Bone Loss in Rheumatoid Arthritis Patients

  • By

  • Takafumi Aritomi

  • Koshiro Sonomoto

  • Shingo Nakayamada

  • Hiroaki Tanaka

  • Atsushi Nagayasu

  • Satoshi Kubo

  • Ippei Miyagawa

  • Ayako Yamaguchi

  • Naoaki Ohkubo

  • Yasuyuki Todoroki

  • Yurie Satoh-Kanda

  • Masanobu Ueno

  • Ryuichiro Kanda

  • Yuya Fujita

  • Masashi Funada

  • Hidenori Sakai

  • Satsuki Matsunaga

  • Masayuki Shinojima

  • Hiroki Kawamura

  • Kazuki Takahashi

  • Miyabi Ando

  • Kazuki Haru

  • Yusuke Miyazaki

  • Kentaro Hanami

  • Masao Nawata

  • Shunsuke Fukuyo

  • Keisuke Nakatsuka

  • Mikiko Tokunaga

  • Kazuyoshi Saito

  • Yoshiya Tanaka

  • April 21, 2026

Share

Original Source(s)

Related Content